Platify 50mg Tablet

About Platify 50mg Tablet

Platify 50mg Tablet contains Eltrombopag, which is used to treat low platelet counts in certain conditions, such as chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, or severe aplastic anemia. Eltrombopag stimulates the bone marrow, which aids in boosting platelet synthesis. It is a anticoagulant medication.

If suggested, take this medication on an empty stomach and follow your doctor's instructions exactly. Do not chew, smash or break it; instead, swallow it whole. Let your doctor know if you have any sensitivities.

Brand Name: Platify

Composition: Eltrombopag

Mechanism of Action:

An agonist of the thrombopoietin receptor is eltrombopag. It causes the bone marrow's thrombopoietin receptors to become more active, which increases platelet synthesis. This keeps the platelet count in a healthy range, which lowers the chance of bleeding.

Uses:

Chronic Immune Thrombocytopenia

Thrombocytopenia in Hepatitis C

Severe Aplastic Anemia

Dosage and Administration:

Usually, the doctor decides the dosage on the underlying condition and the platelet count. Typically, a starting dose of 25 mg once daily is administered; however, this can be changed based on platelet counts and response.

Side Effects:

Nausea

Headache

Fatigue

Liver enzyme changes

Risk of blood clots

Diarrhea

Muscle Pain